An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity

NCT01096979 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Subcutaneous Abdominal Adiposity

Interventions

DRUG: LIPO-102
DRUG: Placebo

Sponsor

Neothetics, Inc